CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$192M
1-Year Return
17.05%
This Quarter Return
-2.78%
1 Year Return
+17.05%
3 Year Return
+45.89%
5 Year Return
+105.96%
10 Year Return
+138.93%
AUM
$550M
AUM Growth
-$25.8M
(-4.5%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
8.93%
Holding
683
New
116
Increased
168
Reduced
251
Closed
120
Top Buys
| 1 |
Intel
INTC
|
$2.17M |
| 2 |
AT&T
T
|
$2.1M |
| 3 |
Chubb
CB
|
$1.93M |
| 4 |
Clorox
CLX
|
$1.89M |
| 5 |
HCA Healthcare
HCA
|
$1.88M |
Top Sells
| 1 |
Wabtec
WAB
|
$2.95M |
| 2 |
Marathon Petroleum
MPC
|
$2.83M |
| 3 |
Occidental Petroleum
OXY
|
$2.71M |
| 4 |
Dow Inc
DOW
|
$2.68M |
| 5 |
Citizens Financial Group
CFG
|
$2.32M |
Sector Composition
| 1 | Technology | 17.49% |
| 2 | Financials | 16.43% |
| 3 | Healthcare | 14.65% |
| 4 | Industrials | 13.25% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Foghorn Therapeutics
FHTX
$326M
| $129K | 0.02% |
25,819
-344
| -1% | -$1.72K |
|
527
Sutro Biopharma
STRO
$89.9M
| $124K | 0.02% |
35,690
-473
| -1% | -$1.64K |
|
528
Valley National Bancorp
VLY
$6.01B
| $120K | 0.02% |
14,004
-99,291
| -88% | -$850K |
|
529
First Horizon
FHN
$11.3B
| $117K | 0.02% |
10,662
-4,311
| -29% | -$47.5K |
|
530
Vir Biotechnology
VIR
$732M
| $117K | 0.02% |
12,462
+2,084
| +20% | +$19.5K |
|
531
Erasca
ERAS
$457M
| $114K | 0.02% |
58,045
+2,979
| +5% | +$5.87K |
|
532
Annexon
ANNX
$238M
| $110K | 0.02% |
46,698
-563
| -1% | -$1.33K |
|
533
Baytex Energy
BTE
$1.67B
| $110K | 0.02% |
24,887
| – | – |
|
534
CytomX Therapeutics
CTMX
$376M
| $105K | 0.02% |
81,352
-1,063
| -1% | -$1.37K |
|
535
BioAtla
BCAB
$31.5M
| $104K | 0.02% |
61,200
-334
| -0.5% | -$568 |
|
536
Century Therapeutics
IPSC
$43.6M
| $103K | 0.02% |
51,520
-655
| -1% | -$1.31K |
|
537
C4 Therapeutics
CCCC
$194M
| $88.3K | 0.02% |
47,456
-591
| -1% | -$1.1K |
|
538
Tenaya Therapeutics
TNYA
$220M
| $87.7K | 0.02% |
34,408
-439
| -1% | -$1.12K |
|
539
Fate Therapeutics
FATE
$116M
| $87.6K | 0.02% |
41,337
-526
| -1% | -$1.12K |
|
540
Kezar Life Sciences
KZR
$29.8M
| $87.6K | 0.02% |
7,358
-99
| -1% | -$1.18K |
|
541
Shattuck Labs
STTK
$74.2M
| $77.5K | 0.01% |
50,973
+610
| +1% | +$927 |
|
|
NGM
542
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $54.8K | 0.01% |
51,176
-545
| -1% | -$583 |
|
|
KRON
543
DELISTED
Kronos Bio
KRON
| $53.8K | 0.01% |
41,351
+563
| +1% | +$732 |
|
544
Nkarta
NKTX
$161M
| $53.7K | 0.01% |
38,645
-551
| -1% | -$766 |
|
545
Adicet Bio
ACET
$60M
| $52.3K | 0.01% |
38,209
-481
| -1% | -$659 |
|
546
Charter Communications
CHTR
$35.7B
| – | – |
-3,017
| Closed | -$1.11M |
|
547
Bridgewater Bancshares
BWB
$442M
| – | – |
-42,108
| Closed | -$415K |
|
548
Conagra Brands
CAG
$9.23B
| – | – |
-64,546
| Closed | -$2.18M |
|
549
Coastal Financial
CCB
$1.66B
| – | – |
-11,545
| Closed | -$435K |
|
550
Cadre Holdings
CDRE
$1.3B
| – | – |
-46,382
| Closed | -$1.01M |
|